Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Masako Yamaji"'
Autor:
Yasunori Ishihara, Mitsuru Fukazawa, Shinya Enomoto, Richard de Solom, Masako Yamaji, Mary Kline, Masakazu Aizawa, Yahong Peng, Osamu Kogawara, Peter C. Giardina, Noor Tamimi, William C. Gruber, Wendy Watson
Publikováno v:
International Journal of Infectious Diseases, Vol 141, Iss , Pp 106942- (2024)
Objectives: Safety and immunogenicity evaluation of a 4-dose series with 20-valent pneumococcal conjugate vaccine (PCV20). Methods: This phase 3, double-blind study randomized healthy Japanese infants to receive 4 doses (3 infant doses, 1 toddler dos
Externí odkaz:
https://doaj.org/article/e0e45f2660a14988b484febfbc2f4db8
Autor:
Miwa Haranaka, James Baber, Yoichiro Ogama, Masako Yamaji, Masakazu Aizawa, Osamu Kogawara, Ingrid Scully, Eleni Lagkadinou, Ӧzlem Türeci, Uğur Şahin, Philip R. Dormitzer, William C. Gruber, Stephen Lockhart
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-7 (2021)
Here the authors provide the interim analysis of an ongoing phase 1/2 study of the BNT162b2 vaccine in healthy Japanese adults. They report mainly mild to moderate local reactions and no serious adverse events as well as good antibody induction one m
Externí odkaz:
https://doaj.org/article/b46c9a1d119e4f05b2b58be147b5baa4
Autor:
Charles Knirsch, Kathrin U. Jansen, Richard de Solom, Masakazu Aizawa, Takuma Yonemura, Masako Yamaji, Megumi Inoue, Chris Webber, Michael W. Pride, William C. Gruber
Publikováno v:
Vaccine. 37(19)
Background Clostridium difficile infection (CDI) is a major global cause of nosocomial and community-acquired infections. Despite potentially severe or fatal complications and frequent recurrence, no preventive vaccine is currently available. This ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e408ca42f7f50a1d60da65cb016dd70
https://pubmed.ncbi.nlm.nih.gov/30962095
https://pubmed.ncbi.nlm.nih.gov/30962095
Autor:
Takehiro, Togashi, Masako, Yamaji, Allison, Thompson, Peter C, Giardina, Masakazu, Aizawa, Scott, Patterson, William C, Gruber, Daniel A, Scott, James, Trammel
Publikováno v:
Pediatric Infectious Disease Journal. 32:984-989
A 13-valent pneumococcal conjugate vaccine (PCV13) containing 6 additional serotypes not included in the 7-valent PCV has been developed to broaden protection against Streptococcus pneumoniae, which is responsible for over 500,000 deaths annually wor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5203dfca66a08b947533d201cb33d237
https://doi.org/10.1097/inf.0b013e318293007e
https://doi.org/10.1097/inf.0b013e318293007e
Publikováno v:
Suicide and Life-Threatening Behavior. 37:593-599
A community-based intervention study for suicide prevention was conducted in six towns (total population 43,964) in Akita Prefecture of Japan according to a quasi-experimental design to reduce suicide rates in rural towns. Public awareness raising ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c23a736720fe91ff8ba153dcd5bb043
https://doi.org/10.1521/suli.2007.37.5.593
https://doi.org/10.1521/suli.2007.37.5.593
Publikováno v:
Community Mental Health Journal. 43:583-590
To clarify the prevalence of depression in a rural community in Japan and to evaluate the social and familial risk factors for depression, with the goal of suicide prevention, a questionnaire survey was conducted on a total of 2,763 elderly persons.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a84a406b07012192164f2cc585f7fe2
https://doi.org/10.1007/s10597-007-9096-5
https://doi.org/10.1007/s10597-007-9096-5
Autor:
Daniel A. Scott, Alejandra Gurtman, Kenji Okada, Mark Cutler, Masakazu Aizawa, Allison Thompson, Takehiro Togashi, William C. Gruber, Masako Yamaji
Publikováno v:
The Pediatric infectious disease journal. 34(10)
13-Valent pneumococcal conjugate vaccine (PCV13) provides broader protection against pneumococcal disease than 7-valent pneumococcal conjugate vaccine (PCV7). This study performed in Japan compared the safety and immunogenicity of PCV13 with PCV7.Hea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ed0202cb761025803094d85b3caa42e
https://pubmed.ncbi.nlm.nih.gov/26121200
https://pubmed.ncbi.nlm.nih.gov/26121200
Autor:
Daniel A. Scott, Beate Schmoele-Thoma, Masako Yamaji, Masanari Shiramoto, Shin Irie, Satoshi Tamai, Todd Belanger, William C. Gruber, Masakazu Aizawa, Christine Juergens
Publikováno v:
Human Vaccines & Immunotherapeutics
This open-label study was designed to assess immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) when administered to Japanese adults aged ≥50 years not previously vaccinated with 23-valent pneumococcal polysaccharide vacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7237ac3e73bffac8f16b93815cad0eb1
https://pubmed.ncbi.nlm.nih.gov/25424792
https://pubmed.ncbi.nlm.nih.gov/25424792
Publikováno v:
BMC Public Health
BMC Public Health, Vol 8, Iss 1, p 334 (2008)
BMC Public Health, Vol 8, Iss 1, p 334 (2008)
Background Family or friends bereaved by suicide are at risk of experiencing complications because of attitudes regarding suicide. It is important that individuals close to those grieving after a death by suicide demonstrate adequate knowledge and co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48eeae07eebb3da1899fb19dc51385f6
https://doi.org/10.1186/1471-2458-8-334
https://doi.org/10.1186/1471-2458-8-334
Autor:
Takehiro Togashi, Kenji Okada, Masako Yamaji, Thompson, Allison, Gurtman, Alejandra, Cutler, Mark, Masakazu Aizawa, Gruber, William C., Scott, Daniel A.
Publikováno v:
Pediatric Infectious Disease Journal; Oct2015, Vol. 34 Issue 10, p1096-1104, 9p